LOVELACE RESPIRATORY RES INST has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are BEIJING ZHICHENG MEDICAL TECH CO LTD, ST JOHNS UNIV and BARCODE DIAGNOSTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Medical technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Spraying devices | |
#5 | Syringes | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Belinsky Steven A | 11 |
#2 | Palmisano William A | 8 |
#3 | Tesfaigzi Yohannes | 3 |
#4 | Shearer Gene M | 1 |
#5 | Walker Vernon E | 1 |
#6 | Gerde Per Magnus | 1 |
#7 | Poirier Miriam C | 1 |
#8 | Leng Shuguang | 1 |
#9 | Walker Dale M | 1 |
Publication | Filing date | Title |
---|---|---|
US2011014625A1 | System and Method for Determining the Health of a Subject Using Polymorphic Risk Markers | |
WO2007123868A2 | Organic thiophosphate antiretroviral agents | |
US2007037156A1 | Metalloproteinase gene polymorphism in copd | |
WO03064682A1 | Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes | |
WO02069996A1 | Induced metaplastic mucous cell apoptosis | |
AU8837901A | Nested methylation-specific polymerase chain reaction cancer detection method | |
EP1028815A1 | Dust gun - aerosol generator and generation |